Re Sapien X4, they seem very cagey when it comes to EOA, etc. Cant imagine Resilia tissue will impact hemodynamics much. Their hemodynamic bottleneck is the 600 sutures used.. So, I'd say hemodynamics will be similar to Sapien 3 i.e. 1.44cm for a 22mm valve.
- Forums
- ASX - By Stock
- AVR
- Ann: Investor Presentation
Ann: Investor Presentation, page-54
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.61 |
Change
-0.090(0.57%) |
Mkt cap ! $301.7M |
Open | High | Low | Value | Volume |
$16.00 | $16.01 | $15.61 | $61.71K | 3.886K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 163 | $15.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.84 | 30 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 163 | 15.610 |
1 | 600 | 15.600 |
1 | 700 | 15.590 |
2 | 320 | 15.560 |
2 | 2534 | 15.550 |
Price($) | Vol. | No. |
---|---|---|
15.840 | 30 | 4 |
15.850 | 9 | 1 |
15.860 | 44 | 1 |
15.990 | 547 | 1 |
16.000 | 591 | 3 |
Last trade - 10.25am 25/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online